Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matt Abernethy currently holds 42,808 shares of NEUROCRINE BIOSCIENCES INC (NBIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matt Abernethy has been a net seller of NBIX stock. They have purchased $0 and sold $14.4M worth of shares.
Matt Abernethy's most recent insider trade was on Mar 4, 2026, when they sold 2,249 shares at $0.00 per share.
Matt Abernethy serves as Executive at NEUROCRINE BIOSCIENCES INC (NBIX). They have executed 45 insider transactions totaling $14.4M over their tenure at the company.
Matt Abernethy holds the position of Executive at NEUROCRINE BIOSCIENCES INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Matt Abernethy has shown a selling trading pattern, with $0 in total purchases and $14.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matt Abernethy was on Aug 13, 2024, when they sold $2.1M worth of NBIX shares. This transaction involved 14,100 shares at $150.38 per share.
Matt Abernethy currently owns 42,808 shares of NEUROCRINE BIOSCIENCES INC (NBIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matt Abernethy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matt Abernethy has 45 Form 4 filings on record as an insider at NEUROCRINE BIOSCIENCES INC.
Set alerts for Matt Abernethy and 40,000+ other insiders.